Postmarketing Surveillance Study for Use of Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (Menactra) in the Republic of Korea
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 04 Jul 2017
At a glance
- Drugs Meningococcal vaccine groups A C Y W-135 conjugate (Primary)
- Indications Meningococcal infections
- Focus Adverse reactions
- Sponsors sanofi pasteur
- 28 Jun 2017 Planned End Date changed from 1 Aug 2019 to 19 Feb 2019.
- 28 Jun 2017 Planned primary completion date changed from 1 Aug 2019 to 19 Feb 2019.
- 28 Jun 2017 Status changed from recruiting to active, no longer recruiting.